Alzheimer’s Disease
Have you or a loved one been diagnosed with Alzheimer’s disease? Are you experiencing troubles with your memory? You may be eligible for a no-cost memory screen to participate in a clinical research trial.
Below you’ll find the clinical trials we are currently enrolling participants in or will be soon.
- A Pivotal Study of Sensory Stimulation in Alzheimer’s Disease (Hope Study, CA-0011)
- The purpose of this study is to test if the daily use of a device called the ‘Sensory Stimulation System’ can help in slowing the progression of Alzheimer’s-memory related issues. The device provides sensory stimulation via over-the-eye glasses and over-the-ear headphones for, up to, several hours daily.
- ClinicalTrials.gov Identifier: NCT05637801
- Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer’s Disease (TargetTau-1)
- The purpose of this study is to assess the effectiveness, safety, and tolerability of a drug (BMS-986446) in participants with Early Alzheimer’s disease. This study is for those with Mild Cognitive Impairment (MCI) or Mild Alzheimer’s disease.
- ClinicalTrials.gov Identifier: NCT06268886
Enroll in Study
If you are interested in scheduling an assessment or learning more about one of our enrolling studies, please fill out the contact form and include the study you are interested in or call us at (813) 353-9613.